Key result
Sevoflurane anesthesia significantly improved postoperative cardiac index (WMD 0.62) and reduced postoperative 24-hour cardiac troponin I concentration (WMD -0.86) compared to propofol in patients undergoing cardiac surgery.
Why the study?
Does sevoflurane anesthesia improve cardioprotective outcomes compared to propofol in patients undergoing cardiac surgery?
Population
Patients undergoing cardiac surgery (15 studies included)
Comparison
Sevoflurane anesthesia vs Propofol anesthesia
Design
Meta-analysis
Follow-up
Up to 24 hours postoperatively and ICU stay
Authors
Loading...
Supports sevoflurane over propofol in cardiac surgery; confirms RCT cardioprotection in meta-analysis.
Meta-Analysis (n=1,646)
Does sevoflurane anesthesia improve cardioprotective outcomes compared to propofol in patients undergoing cardiac surgery?
Mean Difference: 0.62 (95% CI 0.33–0.92)
p-value: p=<0.001
Sevoflurane anesthesia during cardiac surgery may offer better cardioprotection than propofol, as evidenced by improved cardiac index, reduced troponin I release, and shorter ICU stays.
Li et al. (2015) conducted a meta-analysis in Cardiac surgery (n=1,646). Sevoflurane vs. Propofol was evaluated on Postoperative cardiac index (WMD 0.62, 95% CI 0.33 to 0.92, p=<0.001). Sevoflurane anesthesia significantly improved postoperative cardiac index (WMD 0.62) and reduced postoperative 24-hour cardiac troponin I concentration (WMD -0.86) compared to propofol in patients undergoing cardiac surgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: